Skip to main content
    X

    XOMA Corp (XOMA)

    Official site

    BIOTECHNOLOGY

    $40.17
    +0.00 (+0.00%)

    Last updated: Jul 14, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    53%(20/38)
    Avg Surprise
    +63.10%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$0.50
    Range$0.50 - $0.50
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.23+119.8%
    60d ago$0.17+185.7%
    30d ago$0.17+185.7%
    7d ago$0.17+185.7%
    Current$0.50
    Revenue Consensus
    $16M
    Range$16M - $16M
    1 analysts
    Period ending Sep 30, 2026
    EPS Consensus$0.52
    Range$0.52 - $0.52
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.38+35.9%
    60d ago$0.26+100.0%
    30d ago$0.26+100.0%
    7d ago$0.26+100.0%
    Current$0.52
    Revenue Consensus
    $16M
    Range$16M - $16M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.64---
    Sep 26EST
    		-$0.52---
    Jun 26EST
    		-$0.50---
    Mar 26
    Reported May 12
    		$0.17$-0.06+414.55%Beat+188.3%
    Dec 25
    Reported Mar 18
    		$0.08$-0.09+188.89%Beat+233.3%
    Sep 25
    Reported Nov 12
    		$0.70$-0.04+1850.00%Beat+144.0%
    Jun 25
    Reported Aug 13
    		$0.44$-0.15+393.33%Beat-47.6%
    Mar 25
    Reported May 13
    		$0.06N/A+122.22%Beat+107.0%
    Dec 24
    Reported Mar 17
    		$-0.06N/A+80.22%Beat+87.8%
    Sep 24
    Reported Nov 7
    		$-1.59$-0.41-287.80%Miss-165.0%
    Jun 24
    Reported Aug 13
    		$0.84$-0.27+411.11%Beat+242.4%
    Mar 24
    Reported May 9
    		$-0.86$-0.81-6.17%Miss+12.2%
    Dec 23
    Reported Mar 8
    		$-0.49$-0.36-36.11%Miss+22.2%
    Sep 23
    Reported Nov 7
    		$-0.60$-0.48-25.00%Miss-25.0%
    Jun 23
    Reported Aug 8
    		$-0.59$-0.52-13.46%Miss-11.3%
    Mar 23
    Reported May 9
    		$-0.98$-0.49-100.00%Miss-206.2%
    Dec 22
    Reported Mar 9
    		$-0.63$-0.47-34.04%Miss-137.7%
    Sep 22
    Reported Nov 3
    		$-0.48$-0.23-108.70%Miss+5.9%
    Jun 22
    Reported Aug 4
    		$-0.53$-0.16-231.25%Miss-82.8%
    Mar 22
    Reported May 5
    		$-0.32$-0.53+39.62%Beat+54.3%
    Dec 21
    Reported Mar 8
    		$1.67$2.27-26.43%Miss+26.5%
    Sep 21
    Reported Nov 4
    		$-0.51$-0.20-155.00%Miss-410.0%
    Jun 21
    Reported Aug 5
    		$-0.29$-0.31+6.45%Beat+12.1%
    Mar 21
    Reported May 6
    		$-0.70$-0.15-366.67%Miss-42.9%
    Dec 20
    Reported Mar 10
    		$1.32$2.00-34.00%Miss+369.4%
    Sep 20
    Reported Nov 5
    		$-0.10N/A+61.54%Beat-150.0%
    Jun 20
    Reported Aug 6
    		$-0.33$-0.38+13.16%Beat+29.8%
    Mar 20
    Reported May 5
    		$-0.49$-0.16-206.25%Miss-333.3%
    Dec 19
    Reported Mar 10
    		$-0.49$-0.27-81.48%Miss-40.0%
    Sep 19
    Reported Nov 5
    		$0.20N/A+141.67%Beat+145.5%
    Jun 19
    Reported Aug 6
    		$-0.47$-0.55+14.55%Beat-104.3%
    Mar 19
    Reported May 6
    		$0.21$-0.12+275.00%Beat+145.7%
    Dec 18
    Reported Mar 7
    		$-0.35$-0.49+28.57%Beat-118.7%
    Sep 18
    Reported Nov 7
    		$-0.44$-0.40-10.00%Miss-22.2%
    Jun 18
    Reported Aug 7
    		$-0.23$-0.36+36.11%Beat-209.5%
    Mar 18
    Reported May 9
    		$-0.46$-0.53+13.21%Beat+70.3%
    Dec 17
    Reported Mar 7
    		$-0.16N/A+54.29%Beat+92.5%
    Sep 17
    Reported Nov 6
    		$-0.36$-0.72+50.00%Beat-
    Jun 17
    Reported Aug 8
    		$0.21N/A-64.41%Miss-
    Mar 17
    Reported May 9
    		$-1.55$-1.29-20.16%Miss-
    Dec 16
    Reported Mar 16
    		$-2.12$-2.36+10.17%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$43.02
    SMA 20$42.51
    SMA 50$42.04
    SMA 200$33.72
    EMA 10$42.50
    EMA 20$42.49
    EMA 50$41.15
    EMA 200$34.74

    MACD

    Line: 0.21Signal: 0.50Hist: -0.29

    ADX

    ADX: 33.1+DI: 22.0-DI: 40.0

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down96.0
    PSAR$45.11

    Bollinger Bands

    Upper Band$45.11
    Lower Band$39.91
    %B Position1225%(Upper)
    Band Width0.05

    RSI (14-Day)

    Neutral
    34.3

    Momentum Oscillators

    Stoch %K30.8
    Stoch %D59.1
    Williams %R-92.7
    ROC (10d)-4.7%
    Momentum-1.98
    CCI (20d)-172.7
    MFI (14d)23.5

    Volatility Measures

    ATR (14d)$0.84(2.1%)
    StdDev (20d)1.30
    Hist Vol36.0%(Moderate)

    Volume Flow

    VWAP$40.17
    OBV-6.1M
    AD Line-4.0M
    CMF (20d)-0.463

    Volume Metrics

    Avg Vol (20d)510.0K
    Vol RatioN/A
    VWMA (20d)$41.14

    Pivot Points

    R3$47.04
    R2$45.50
    R1$42.84
    Pivot Point$41.30
    S1$38.64
    S2$37.10
    S3$34.44

    Advanced Oscillators

    TSI9.83
    Ultimate Osc44.8
    KST25.55

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$12.32M$13.76M$9.35M$13.13M$15.91M$8.71M$7.20M$11.09M$1.49M$1.83M$830,000$1.66M
    Cost of Revenue$0$884,000$0$0$0$864,000$0$0$0$25,000$0$0
    Gross Profit$12.32M$13.76M$9.35M$13.13M$15.91M$8.71M$7.20M$11.09M$1.49M$1.83M$830,000$1.66M
    Operating Expenses$12.80M$11.57M$10.68M$8.53M$9.98M$15.97M$22.84M$21.16M$8.49M$21.77M$6.62M$7.62M
    R&D$49,000$281,000$69,000$69,000$1.29M$864,000$817,000$1.16M$33,000$25,000$25,000$39,000
    SG&A$11.86M$10.41M$9.73M$7.80M$8.15M$6.99M$8.02M$11.00M$8.46M$7.26M$6.37M$5.78M
    Operating Income$-480,000$2.18M$-1,330,000$4.60M$5.93M$-7,253,000$-15,640,000$-10,079,000$-7,004,000$-19,934,000$-5,787,000$-5,957,000
    Interest Income$3.54M$0$18.00M$0$0$0$0$19.32M$0$0$0$0
    Interest Expense$3.36M$3.03M$3.30M$3.24M$3.47M$3.39M$3.49M$3.40M$3.55M$569,000$0$0
    Income Before Tax$4.47M$6.16M$14.10M$9.19M$2.37M$-9,626,000$-17,243,000$15.98M$-8,595,000$-19,752,000$-5,509,000$-5,400,000
    Income Tax Expense$1,000$0$49,000$0$0$0$0$0$0$0$0$0
    Net Income$4.46M$6.10M$14.05M$9.19M$2.37M$-3,968,000$-17,243,000$15.98M$-8,595,000$-20,109,000$-5,509,000$-5,400,000
    EBITDA$5.51M$7.10M$664,000$13.41M$6.81M$-5,670,000$-13,259,000$276,000$-4,736,000$-19,675,000$-5,285,000$-5,175,000
    EBIT$4.28M$5.96M$-603,000$12.43M$5.83M$-6,232,000$-13,750,000$71,000$-5,044,000$-19,934,000$-5,509,000$-5,400,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XOMA

    News

    XOMA Royalty Corp (XOMA) Stock News Today

    The article provides current stock information for XOMA Royalty Corp (XOMA), including its stock price, market capitalization, and P/E ratio. It indicates that more news and analysis for XOMA is forthcoming...

    TradingKey•8/7/26•Neutral

    FMR LLC (XOMA) cuts XOMA Royalty stake to 0.0% in latest 13G/A

    FMR LLC and Abigail P. Johnson have filed an amended passive investment disclosure (Schedule 13G/A) for XOMA Royalty Corporation, indicating that they no longer beneficially own any shares. As of July 31, 2026...

    Stock Titan•8/7/26•Neutral

    FMR LLC boosts disclosure in XOMA Royalty Corporation (XOMA) with 9.1% stake

    FMR LLC has disclosed a 9.1% stake in XOMA Royalty Corporation (XOMA) through an amended Schedule 13G/A filing. As of June 30, 2026, FMR LLC beneficially owns 1,605,532.14 shares...

    Stock Titan•8/6/26•Neutral

    US98419J206 Stock Price and Chart — MUN:US98419J206

    This article provides detailed financial information and key statistics for XOMA Royalty Corporation (US98419J206) traded on the Munich Stock Exchange. It covers market capitalization, dividend yield, EPS, revenue...

    TradingView•8/3/26•Neutral

    Vanguard Capital Management (XOMA) discloses 571,823-share passive stake in XOMA

    Vanguard Capital Management LLC has filed an amended Schedule 13G, disclosing a passive stake of 571,823 shares in XOMA Royalty Corp, representing 3.23% of the outstanding common stock as of June 30...

    Stock Titan•7/31/26•Neutral

    XOMA Competitors

    CompanyTicker
    Evotec SE ADREVO
    Senseonics Holdings, Inc. Common StockSENS
    Regenxbio IncRGNX
    AngioDynamics IncANGO
    Sight Sciences IncSGHT
    Tilray IncTLRY
    Evolus IncEOLS
    Brainsway LtdBWAY

    Sector: Healthcare

    XOMA Bull Case vs Bear Case

    Bull case

    • XOMA beat EPS estimates in 87.5% of its last 8 reported quarters.

    XOMA Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    396.6%
    EPS estimate (fiscal period ending Jun 30, 2026)
    $0.50
    Estimate revisions (30 days, fiscal period ending Jun 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About XOMA

    Does XOMA pay dividends?

    XOMA Corp (XOMA) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with X

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In